Literature DB >> 8393054

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea.

M K Bhan1, J F Lew, S Sazawal, B K Das, J R Gentsch, R I Glass.   

Abstract

A cohort of newborns in New Delhi who were nosocomially infected with rotavirus during their first days of life were followed twice weekly for 14-23 months to determine whether neonatal infection protected them against subsequent episodes of rotavirus diarrhea. Infection occurred in 60% by the fourth day of life, was asymptomatic, and was caused predominantly by an unusual rotavirus strain (G9 P11) not previously identified in humans. The 148 children with neonatal rotavirus infection had 46% fewer attacks of rotavirus diarrhea in the follow-up period than the 56 infants without nosocomial infection (0.23 vs. 0.42 episodes/child-year, P < .05). This protection was concentrated among infants in their first year of life and was not associated with a significant decrease in disease severity. Consideration of this strain as a vaccine candidate will require further assessment of its natural protection under field conditions.

Entities:  

Mesh:

Year:  1993        PMID: 8393054     DOI: 10.1093/infdis/168.2.282

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Detection and characterization of rotaviruses in hospitalized neonates in Blantyre, Malawi.

Authors:  N A Cunliffe; S Rogerson; W Dove; B D M Thindwa; J Greensill; C D Kirkwood; R L Broadhead; C A Hart
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent.

Authors:  N A Page; A D Steele
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 4.  Epidemiology of rotavirus in India.

Authors:  V Jain; U D Parashar; R I Glass; M K Bhan
Journal:  Indian J Pediatr       Date:  2001-09       Impact factor: 1.967

Review 5.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

6.  Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

Authors:  M Ramachandran; A Vij; R Kumar; B K Das; J R Gentsch; M K Bhan; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

7.  Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin.

Authors:  N A Cunliffe; B K Das; M Ramachandran; M K Bhan; R I Glass; J R Gentsch
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 8.  Performance of rotavirus vaccines in developed and developing countries.

Authors:  Victoria Jiang; Baoming Jiang; Jacqueline Tate; Umesh D Parashar; Manish M Patel
Journal:  Hum Vaccin       Date:  2010-07

Review 9.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis.

Authors:  S Aijaz; K Gowda; H V Jagannath; R R Reddy; P P Maiya; R L Ward; H B Greenberg; M Raju; A Babu; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.